GlaxoSmithKline’s difficult year continued today as shares tumbled on a warning that it no longer expects to improve a key measure of earnings.

GlaxoSmithKline and Swiss rival Novartis are to create a consumer healthcare powerhouse as part of a string of deals in the pharmaceuticals sector today.

HALF a century after he left the gardaí, John O’Leary still regrets taking the £89 he was offered in lieu of leaving his pension contributions with the force.